Apple Expands ResearchKit Studies for Autism, Epilepsy and Melanoma

Apple Expands ResearchKit Studies for Autism, Epilepsy and Melanoma

A few months ago, the ResearchKit landed with apps focused on Parkinson's disease and diabetes, cardiovascular disease, asthma and breast cancer. Today, Apple announced the first significant expansion of studies conducted with its framework open code.

From now on, ResearchKit will also be used to carry out studies on autism, epilepsy and melanoma. Researchers at Duke University, Johns Hopkins University and Oregon Health & Science University are already working on these diseases by obtaining valuable data from iPhone users.

"We are honored to work with top medical institutions and provide them with tools to better understand disease and perhaps help people lead healthier lives," said Jeff Williams, senior vice president of operations at Apple. “In just six months, apps with ResearchKit studying everything from asthma to diabetes to Parkinson's disease are already bringing new knowledge to scientists around the world and more than 100,000 participants are choosing to share their data to advance science and medical research. . ”

In addition to the academic studies themselves (currently conducted in Germany, Austria, the United States, China, Hong Kong, the United Kingdom and Switzerland), more than 50 researchers and developers have also been working to expand ResearchKit with new modules , active tasks and personalized questionnaires exploring the open nature of framework. In mid-July, it is worth remembering that it was also updated with support for the iPad and other news.

a great initiative, without a doubt.